Aceclofenac use restricted

Further information
MHRA Drug Safety Update

The use of aceclofenac is now contraindicated in patients with certain established cardiovascular diseases, including ischaemic heart disease, peripheral arterial disease, cerebrovascular disease and congestive heart failure. Treatment with the drug should be initiated only after careful consideration of any significant cardiovascular risk factors.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Trial of interferon beta in COVID-19 patients begins in UK

Trial of interferon beta in COVID-19 patients begins in UK

A global phase III clinical trial to evaluate an inhaled...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

New muscle spasm treatment option

New muscle spasm treatment option

Myopridin (pridinol) can be prescribed to treat skeletal...